Clinical Trial Update: Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating extended adjuvant therapy with letrozole in breast cancer patients who completed 5 years of toremifene.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FARESTON (toremifene citrate)
• FEMARA (letrozole)

Snippet

Sponsor: Korean Breast Cancer Study Group | Conditions: Breast Cancer | Phase 4 | Status: UNKNOWN